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Abstract 
 
For decades, it has been known that the serous cavities, which includes the peritoneal, 
pleural and pericardial cavities, harbour large numbers of macrophages. In particular, due to 
the ease of isolating these cells, the peritoneal cavity has been used as a convenient source 
of macrophages to examine many facets of macrophage biology over the last 50-60 years. 
Despite this, it is only recently that the true heterogeneity of serous cavity mononuclear 
phagocyte compartment, which includes macrophages and dendritic cells, has been 
revealed. Advances in technologies such as multi-parameter flow cytometry and the 
‘OMICs’ revolution have uncovered the presence of distinct populations of mononuclear 
phagocytes in the serous cavities. Given that peritoneal macrophages have been implicated 
in many pathologies, including peritonitis, pancreatitis, endometriosis and acute liver injury, 
it is imperative to understand the biology of these cells. Here, we review the recent 
advances in understanding the identity, origin and function of discrete serous cavity 
mononuclear phagocyte subsets in homeostasis and how these may change when 
homeostasis is perturbed, focusing on peritoneal and pleural cavities and highlighting 
differences in the mononuclear phagocytes found in each. 
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Introduction 
Mononuclear phagocytes (MPs), including macrophages and dendritic cells, are present in 
every tissue of the body where carry out important and distinct roles in protective immunity. 
However, it is increasingly clear that these cells are also crucial for the maintenance of tissue 
homeostasis, as well repair of damaged tissue following injury, infection or inflammation. 
The serous cavities, which includes the peritoneal, pleural and pericardial cavities, contain 
large numbers of MPs, but it is only recently that the heterogeneity of this compartment has 
been dissected. In this review, we will begin by discussing the recent advances in 
understanding the phenotypic identity, developmental origin and function of distinct MP 
subsets, and in particular, macrophages in the serous cavities during homeostasis before 
describing how these change in different disease contexts.   
 
The Anatomy of the Serous Cavities 
The peritoneal cavity is the small fluid filled space between the mesothelial lining of the 
abdominal wall (parietal peritoneum) and the equivalent lining of the abdominal organs 
(visceral peritoneum). With a similar surface area to that of the skin, the peritoneum is the 
largest serous membrane of the human body [1]. Notably the peritoneum differs between 
the sexes. Whereas in males the peritoneum forms a closed cavity, in females the 
peritoneum is discontinuous at the fimbrial openings of the fallopian tubes and the ovaries 
are covered in a single layer of cuboidal epitheloid cells, not visceral peritoneum [1]. Thus, 
the composition of the peritoneal fluid will differ between males and females due to the 
presence of ovarian exudate and retrograde passage of material from the reproductive 
tract. In contrast, male reproductive organs are located outwith the abdominal cavity. The 
pleural cavity is the serous cavity of the thorax and pericardial cavity surrounds the heart. 
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However, because the parietal and visceral mesothelia adhere to one another under normal 
physiological conditions in these cavities [2], they are often referred to as ‘potential spaces’. 
In each of these cavities the mesothelium is a single layer of squamous epithelial cells which 
sits on top of a layer of connective tissue. The mesothelium continually secretes fluid, with 
around 5-20ml present in the human peritoneal cavity under normal physiological settings 
[1]. Similar to type II pneumocytes, mesothelial cells of the peritoneum, pleurae and 
pericardia have lamellar bodies, which are composed of lipid membranes and protein 
complexes of surfactant proteins [1]. Balanced release of lipids, surfactant proteins and fluid 
generates a glycocalyx over the surface of mesothelial cells, which creates a layer of static 
fluid that acts as lubricant and allows frictionless movement of the organs, for instance 
during intestinal peristalsis in the abdomen, expansion and contraction of the lungs in the 
thorax and the beating of the heart. However, the majority of cavity fluid is not static and 
moves in a well-defined manner. For instance, in the peritoneal cavity fluid moves upwards 
from the lower to upper abdominal cavity due to respiration and then returns under the 
control of gravity. The cavity fluid is rich in water, electrolytes, proteins and immune cells, 
including T- and B-cell subsets and mast cells that co-exist alongside the large mononuclear 
phagocyte (MP) compartment [3].  
 
Unravelling Mononuclear Phagocyte Heterogeneity in the Serous Cavities 
In mice, the peritoneal and pleural cavities are known to house at least two distinct 
macrophages subsets, which are present in a variety of strains, including C57BL/6, BALB/c, 
129/S6, FVB/N, SJL/J and Rag1–/– mice [4]. These subsets were originally defined by their 
differential expression of the pan-macrophage marker, F4/80, and MHC class II (MHCII) [4]. 
The majority of macrophages in the healthy cavity express high levels of F4/80 and only low 
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levels of MHCII, and are sometimes referred to as ‘large’ peritoneal macrophages (LPM) [4] 
(Figure 1). These F4/80hi cells possess characteristic macrophage morphology, including 
abundant cytoplasmic vacuoles, are highly phagocytic and are reliant on CSF1R signalling 
for their development and maintenance [4-8]. Furthermore, they express CD64 (the high 
affinity IgG receptor) and Mer tyrosine kinase (MerTK) [9], two markers that are now 
commonly used to identify tissue macrophages [9,10]. While there is general consensus that 
these F4/80hi cells represent tissue macrophages, the composition of the F4/80–/lo MHCII+ 
population that co-inhabits the serous cavities has been a source of controversy [4-6,11-15]. 
This is due to divergent approaches taken to characterise these cells by different 
investigators and the realisation that the marker CD11c, which was previously considered to 
be dendritic cell (DC) specific, is expressed by many macrophages, including some of those 
present in the serous cavities [5,6,14,15]. Thus, while Ghosn et al. [4] were first to thoroughly 
compare the biology of F4/80hi and F4/80lo MPs, their exclusion of all CD11c+ cells as DC to 
identify the so-called ‘small’ peritoneal macrophages (SPM) will have underestimated the 
heterogeneity of the F4/80–/lo MHCII+ macrophage compartment. More recent studies have 
adopted CSF1R expression as a universal marker of cells of the macrophage lineage in the 
serous cavities [6,16,17]. Notably, unlike other tissues where CSF1R protein expression is 
difficult to measure, it can readily be detected on the surface of peritoneal exudate cells 
(PEC) (Bain & Jenkins, Methods in Molecular Biology, In press). Indeed, F4/80–/lo MHCII+ cells 
that lack the CSF1R represent conventional DC (cDC), since they arise from CCR2-
independent precursors, rely on Flt3L for their development, and can be divided into cDC1 
and cDC2 subsets based on expression of XCR1/CD103 and CD11b [6,15,18] (Figure 1), as 
in other tissues [19]. The vast majority of CSF1R expressing F4/80–/lo MHCII+ cells represent 
cells of the macrophage lineage, as they are acutely dependent on CSF1 for their 
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development/maintenance [6] (SJJ, unpublished observations) and, like their F4/80hi co-
inhabitants, express the macrophage-restricted transcription factor, MafB [20]. However, 
around a quarter of CSF1R+ F4/80–/lo MHCII+ cells are labelled in Zbtb46-GFP reporter mice 
[20], which have been used extensively to identify cells of the DC lineage [21,22]. 
Consistently, our recent work has shown that the CSF1R+ F4/80–/lo MHCII+ population is 
heterogeneous for CD11c expression and that the CD11c+ fraction is partially affected by 
Flt3L deficiency and comprises both CCR2-dependent and CCR2-independent cells. Thus, 
the CSF1R+ F4/80–/lo MHCII+ compartment seemingly contains a small population of DC. 
Notably, markers such as CD24, CD26, CD64, CD272 and MerTK, which have been used to 
distinguish macrophages and cDC in other tissues [9,10,19,23-25], are not useful for division 
of the CSF1R+ F4/80–/lo MHCII+  compartment in the serous cavities [5,15] (and CCB & SJJ, 
unpublished observations).  
 In addition to the phenotypic markers noted above, novel markers have been 
identified through genome-wide transcriptional profiling by the Immunological Genome 
Consortium (Immgen) and others [9,11,26,27], which aid identification of cavity 
macrophages. CD102 (intercellular adhesion molecule  2, ICAM2) has emerged as a 
signature marker of F4/80hi macrophages, which also express high levels of CD73, CD93, 
CD9 and CD49F [11,13,26]. While most F4/80hi macrophages also express Tim4, the 
phagocytic receptor that recognises phosphatidylserine on apoptotic cells, Tim4– F4/80hi 
macrophages are present under normal physiological conditions and, as discussed below, 
their number is highly dependent on the strain, age and sex of the animal. Notably, none of 
these markers are expressed by CSF1R+ F4/80–/lo MHCII+ macrophages to any significant 
level. Instead, CD226 (DNAM-1) has been established as a useful marker of mature CSF1R+ 
F4/80–/lo MHCII+ macrophages in the serous cavities under homeostatic conditions [5,14,15]. 
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Similarly, we have recently shown that expression of CD206 (mannose receptor) and 
constitutive production of the immunoregulatory cytokine resistin-like molecule (RELM)a are 
key traits of these cells [5]. Of these, RELMa expression appears to best discriminate the 
macrophages from the DC component of CSF1R+ CD11c+ F4/80–/lo MHCII+ cells. While these 
molecules are typically associated with ‘alternative activation’ of macrophages, expression 
of CD206 and RELMa is independent of the IL-4–IL-4R axis (CCB & SJJ, unpublished data) 
that defines ‘alternatively activated’ macrophages [28]. Thus, CD206 and RELMa are default 
properties of mature CSF1R+ CD11c+/– F4/80–/lo MHCII+ macrophages. 
Studies examining the immune cell composition in the peritoneal fluid of humans 
have shown that mononuclear phagocytes are present in the peritoneal cavity, even in the 
absence of infection [29], and constitute around 50% of all leukocytes [30]. These display 
classical macrophage features, including expression of CD11b, CD14, CD68, CD64, MerTK, 
VSIG4 and CD49F, as well as having avid phagocytic activity, consistent with some of their 
counterparts in mice [29-31]. However, whether functionally distinct macrophage subsets 
exist amongst this population under normal physiological conditions requires further study. 
 
The Ontogeny of Serous Cavity Macrophages 
Classically, tissue macrophages have been considered to be replenished by blood 
monocytes, which themselves are rapidly replaced by highly proliferative bone marrow (BM) 
progenitors, as part of a linear mononuclear phagocyte system (MPS) first proposed by van 
Furth and colleagues in the 1970’s [32]. However, as described elsewhere in this volume, 
our understanding of macrophage ontogeny has been completely re-written in recent years 
with the realisation that many tissue macrophages appear to exist independently of blood 
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monocytes and instead derive from progenitors arising from yolk sac mesenchyme or foetal 
liver (see review by Ginhoux & Guilliams [33]). These progenitors seed tissues during 
development and, in many cases, the ‘embryo-derived’ macrophages they give rise to are 
able to maintain themselves for much of adult life through in situ self-renewal and longevity, 
under normal physiological conditions and even following an inflammatory challenge 
[34,35]. The developmental origin of peritoneal macrophages has been a particular source 
of controversy. Although much of the historical work examining peritoneal macrophage 
origin concluded that these cells were of BM origin  [36-39], these studies relied on 
techniques such as full body radiation BM chimeras, which suffer from the fact that radiation 
exposure results in ablation of tissue macrophages. Thus, the replacement under these 
conditions may not reflect mechanisms present under physiological conditions. More 
recently, fate mapping by genetic means has been developed. For instance, by using the 
Cx3cr1Cre-ERT2.Rosa26eYFP strain in an attempt to label circulating monocytes, Jung and 
colleagues [40] concluded that peritoneal F4/80hi macrophages exist independently of 
monocyte input, findings supported by studies using parabiotic mice [14,35] and dye-
labelling studies [41]. Somewhat paradoxically, tracing of HSC-derived cells using an 
inducible fate mapping system based on Kit (CD117) expression suggested that peritoneal 
F4/80hi macrophages are rapidly replenished by BM, at a rate faster than colonic 
macrophages [42], which are known to depend on monocytes for their maintenance [43,44]. 
We recently offered an explanation for the discrepancies in the literature, by using tissue-
protected BM chimeric mice to demonstrate that the requirement for peritoneal F4/80hi 
macrophage replacement by BM-derived cells is highly sex-dependent; high and low rates 
of replacement in male and female mice, respectively [5] (Figure 1). Interestingly, although 
identical populations of MPs are found in the pleural cavity, the turnover of pleural F4/80hi 
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macrophages is high and unaffected by sex [5], suggesting that local environmental factors 
that control both the differentiation and rate of turnover of macrophages may differ in 
distinct cavities (see below).  
An alternative mechanism for the replenishment of serous cavity F4/80hi 
macrophages has been proposed recently. Audzevich et al. [45] have suggested that 
macrophages can also arise from pre/pro-B cells in both peritoneal and pleural cavities. By 
using the Mb1iCre.Rosa26LSL-eYFP strain to fate-map B cell progenitors, high levels of labelling 
were detected in peritoneal and pleural macrophages, but not in most other tissue 
macrophages under steady state conditions. However, the relative dominance of these 
pre/pro-B cell derived macrophages with age and sex remains unclear, as does whether 
they differ functionally from their embryo- or monocyte-derived counterparts. 
The origin of F4/80–/lo MHCII+ MPs has also been established recently. Fate-mapping 
of BM cells and monocytes, as well as parabiosis demonstrate that these cells are 
dependent on replacement from BM and are short-lived [5,8,13,14]. The majority of the 
CSF1R+ F4/80–/lo MHCII+ MPs are replenished in a CCR2-dependent manner, suggesting 
they depend on Ly6Chi classical monocytes (Figure 1). Indeed, classical Ly6Chi monocytes 
can be found in the naïve serous cavities where they appear to mature through a monocyte 
‘waterfall’, whereby they lose Ly6C expression while gaining expression of MHCII to 
replenish the mature CSF1R+ F4/80–/lo MHCII+ MPs [5]. A small fraction of the CSF1R+ F4/80–
/lo MHCII+ MPs that express CD11c but lack RELMa expression appear to be less dependent 
on CCR2, and most likely represent the small DC population within this population [5]. The 
CSF1R– DCs amongst the F4/80–/lo MHCII+ MP compartment do not rely on cell intrinsic 
CCR2 signalling or their maintenance, suggesting that CCR2 utilisation is relatively unique 
to cells of the monocyte/macrophage lineage. Both subsets of CSF1R+ F4/80–/lo MHCII+ MPs 
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distinguished by CD11c also appear to have discernibly longer half-lives than the CSF1R– 
DCs, as determined by pulse-chase studies [5].  
As well as fulfilling discrete functions under normal conditions, CSF1R+ F4/80–/lo 
MHCII+ macrophages may also act as precursors of F4/80hi macrophages. Indeed, our recent 
fate mapping using CD11cCre.Rosa26LSL-eYFP mice suggests that CSF1R+ F4/80–/lo MHCII+ 
macrophages can mature into F4/80hi macrophages [5] and adoptively transferred F4/80–/lo 
MHCII+ peritoneal cells can adopt an F4/80hi macrophage phenotype if there is niche 
availability [13]. Whether all CSF1R+ F4/80–/lo MHCII+ macrophages can mature into F4/80hi 
macrophages or if this is a property of a subset of these cells is unknown. 
While it has been known for years that macrophages have the ability to proliferate in 
situ [46], proliferation is often considered to be an exclusive property of embryo-derived 
macrophages, thereby explaining their ability to persist throughout adulthood. However, we 
have recently shown that both embryo- and BM-derived peritoneal F4/80hi macrophages 
can, and do, proliferate. In fact, at least in the peritoneal cavity, BM-derived F4/80hi 
macrophages tend to have a higher level of proliferation than their embryo-derived 
counterparts [5]. Consistently, lower levels of proliferation are observed in F4/80hi 
macrophages from the cavities of monocytopenic Ccr2–/– mice (CCB & SJJ, unpublished 
observations). Furthermore, all F4/80–/lo MHCII+ MPs proliferate under normal physiological 
conditions [5], confirming that in situ proliferation is not an exclusive property of long-lived 
macrophages. 
The parameters that limit the overall lifespan of the peritoneal F4/80hi macrophage 
population remain unclear. It has been proposed that replacement by BM-derived cells may 
occur due to proliferative exhaustion of embryo-derived F4/80hi macrophages. However, 
this does not appear to be the case in the serous cavities, as F4/80hi macrophages of 
 11 
different origins show identical proliferative responses to exogenous CSF1 administration 
[5]. Moreover, turnover of peritoneal F4/80hi macrophages from the BM does not simply 
reflect a process of displacement that arises from competition with continually-recruited 
monocytes because sex-dependent differences in F4/80hi macrophage turnover are also 
apparent in Ccr2–/– mice, in whom monocyte recruitment is markedly diminished. Thus, 
further work is needed to determine the factors that govern macrophage longevity. 
 
Transcription Factors in Cavity Macrophage Differentiation 
As well as identifying additional markers for more in-depth characterisation of cavity MPs, 
recent transcriptional profiling has also identified transcription factors involved in their 
differentiation. Three groups simultaneously identified the transcription factor GATA6 as a 
key regulator of peritoneal F4/80hi macrophage differentiation, demonstrating that mice 
with myeloid-specific deletion of Gata6 have fewer F4/80hiCD102+ macrophages [11,17,26]. 
Furthermore, GATA6 deficiency affects survival, proliferation and function of F4/80hi 
macrophages [11,17,26]. For instance, the TGFb2-dependent support provided by 
peritoneal macrophages for B1 cell class switching was reduced in the absence of GATA6 in 
myeloid cells [26] (see below). Notably, GATA6 is also expressed by pleural F4/80hi 
macrophages and similar defects in macrophage proliferation were seen in the pleural cavity 
[11]. Interestingly, similar breakdown in peritoneal F4/80hi macrophage differentiation is 
seen in mice with global or myeloid-specific deletion of CCAAT/enhancer binding protein 
(C/EBP)b [13], although whether C/EBPb and GATA6 control non-overlapping aspects of 
F4/80hi macrophage differentiation is unknown. Rather than controlling survival, KLF2 and 
KLF4 appear to control the expression of apoptotic cell receptors, such as Tim4, and induce 
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negative regulators of TLR signalling, ensuring F4/80hi macrophages clear apoptotic cells in 
a non-inflammatory manner [47]. 
CSF1R+ F4/80–/lo MHCII+ MPs are unaffected by GATA6 deficiency and instead rely 
on IRF4 for their differentiation, with markedly fewer of these cells in Irf4–/– and CD11c-
Cre.Irf4fl/fl mice [14]. Interestingly, a proportion of CSF1R+ F4/80–/lo MHCII+ MPs remain in the 
absence of IRF4, but whether these represent a distinct IRF4-independent population 
remains unclear. Furthermore, the identity of other transcription factors involved in CSF1R+ 
F4/80–/lo MHCII+ MP differentiation remains to be determined. 
 
Environmental Factors Controlling Macrophage Differentiation  
Like most other tissue macrophages, those in the serous cavities depend on CSF1 for their 
differentiation and survival, and under normal conditions are independent of CSF2 [6]. 
However, the other local environmental factors that control the phenotypic and functional 
tissue-specific imprinting of serous cavity macrophages are only beginning to be uncovered. 
In the peritoneal cavity, the omentum has been implicated in the maintenance of F4/80hi 
macrophages. The omentum is an intra-abdominal adipose tissue comprised of two layers 
of mesothelial cells that enclose a collection of adipocytes and leukocytes, with the latter 
aggregating in clusters known as ‘milky spots’ [48]. For decades, it has been appreciated 
that the omentum is important for peritoneal defence, principally due to its ability to adhere 
to sites of inflammation and remove foreign material [48]. Early studies suggested that the 
omentum was a local source of macrophage progenitors [49], which was supported by dye-
labelling studies showing that macrophages appear to shuttle between the omentum and 
the peritoneal cavity [50,51]; a process facilitated by the lack of mesothelium over milky 
spots [48]. Moreover, omentectomy results in a reduction in the number of macrophages in 
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the peritoneal cavity [52] and peritoneal macrophages are known to accumulate in milky 
spots during peritoneal inflammation [26]. Despite this, definitive proof of a precursor-
product relationship between omental macrophages and those in the peritoneal cavity is 
lacking. Studies of this nature have been hampered by the inability to distinguish resident 
omental macrophages from those potentially transiting to/from the peritoneal cavity, as 
both express F4/80 and CD11b, albeit at varying levels. However, with the identification of 
additional peritoneal macrophage markers such as CD102, it has been shown that cells with 
the phenotypic identity of peritoneal F4/80hi macrophages are present in the omentum [26]. 
Nevertheless, the nature of these cells remains poorly understood.  
Rather than acting as a source of peritoneal macrophages, other work has suggested 
that the omentum could be the source of factors that drive macrophage differentiation or a 
vessel for differentiation to occur. For instance, it was demonstrated that omental tissue 
could support macrophage differentiation from BM precursors, suggesting that omental 
cells are a rich source of CSF1 [51,53]. More recently, production of the vitamin A 
metabolite, retinoic acid (RA), by omental stromal cells has been proposed to control a large 
proportion of the transcriptional profile of F4/80hi peritoneal macrophages through 
induction of GATA6 [26]. Indeed, mice reared and maintained on a vitamin A deficient 
(VAD) diet have fewer mature F4/80hi macrophages, although notably, the effects of VAD 
are only evident after 9 weeks of age [26], suggesting other sources of RA may play a key 
role in early life or that there is a switch from independence to dependence on RA for 
macrophage maintenance with age. It must also be noted that maintenance on VAD diet 
can result in the generation of systemic inflammation, including in the peritoneal cavity [54]. 
Therefore, it could be that the breakdown in macrophage differentiation in VAD mice could 
be secondary to wider inflammatory effects [55]. The CSF1R+ F4/80–/lo MHCII+ macrophage 
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subset may also play a role in providing active RA, as they express high levels of 
retinaldehyde dehydrogenase A2 (RALDH2), one of the enzymes that catalyses the synthesis 
of RA from dietary vitamin A [5,14,56]. However, the significance of this has never been 
tested experimentally. Whether adipose in the pleural and pericardial cavities also acts to 
support macrophage differentiation in these sites is unknown.  
The commensal microbiota and their products have been shown to influence the 
differentiation of a number of macrophage populations, including those in the colon, skin, 
lung and even the central nervous system [44,57-61]. Moreover, recent work has shown that 
administration of broad-spectrum antibiotics led to a selective loss of mature peritoneal 
CSF1R+ F4/80–/lo MHCII+ macrophages, suggesting their maintenance/differentiation is 
influenced by the presence of the commensal microbiota [14]. However, antibiotic treatment 
can result in cell stress, such as mitochondrial dysfunction [62], and it remains possible that 
CSF1R+ F4/80–/lo MHCII+ macrophages could be more susceptible to antibiotic-mediated 
stress. Thus, analysis of these cells from germ free mice will be valuable to dissect the role 
of the microbiota in their differentiation. 
As mentioned above, the turnover of F4/80hi peritoneal macrophages is also 
influenced by the sex of the animal and more of these cells are present in the peritoneal 
cavities of female mice [63,64]. Although the local factors responsible for creating this sex 
dimorphism are not yet clear, peritoneal macrophages express estrogen receptors and 
undergo transcriptional reprogramming and enhanced proliferation in response to 
exogenous estrogen [65]. Furthermore, oophorectomy (or ovariectomy) leads to a reduction 
in the number of peritoneal macrophages [63,65], suggesting the presence of the female 
reproductive tract in the female peritoneal cavity alters the biology of the resident 
macrophages.  
 15 
Homeostatic functions of Cavity Macrophages 
The presence of such phenotypically and transcriptionally distinct macrophage populations 
suggests specialised functions for each of these cells. As described above, F4/80hi 
macrophages express an array of phagocytic receptors (including Tim4, MerTK, CD36)[9,16] 
and have avid phagocytic ability [4], suggesting that a primary function of these cells is to 
scavenge apoptotic and senescent cells (Figure 2). These properties may also allow them to 
regulate surfactant levels in serous cavity fluid similar to the regulation of pulmonary 
surfactant by alveolar macrophages. Indeed, F4/80hi macrophages express genes that are 
involved in lipid uptake and metabolism, such as Cd36, Alox15, Fabp4 and Cav1 [9,11,66]. 
F4/80hi macrophages also express high levels of CXCL13, the ligand for CXCR5 which is 
expressed highly by serous cavity B1 cells and is instrumental for their homing to the serous 
cavities [67]. Serous cavity B1 cells are rich sources of natural antibodies which are important 
for early protection against a variety of pathogens (see review [68]). However, B1 cells can 
also class switch to IgA production, a process that is promoted by TGFb2 from F4/80hi 
macrophages [26]. Local retinoic acid (RA) can also induce expression of gut homing 
molecules such as a4b7 and CCR9 on B1 cells, allowing them to migrate to the intestinal 
lamina propria where they can secrete IgA [69,70]. Thus, in addition to local roles, F4/80hi 
macrophages may also support intestinal immunity. In addition to these homeostatic 
functions, F4/80hi macrophages act as sentinels of the innate immune system and respond 
rapidly to microbial stimulation to recruit other innate immune effector cells (see below).  
 The homeostatic function of the F4/80–/lo MHCII+ MPs is less well understood. 
Compared with F4/80hi macrophages, they appear less able to phagocytose apoptotic cells 
[13] but are more able to take up bacteria and produce nitric oxide in response to LPS 
stimulation in vivo [4] (Figure 2). In addition, their high expression of MHCII and 
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costimulatory molecules, such as CD80 and CD86, suggests a role for antigen presentation. 
Indeed, all subsets of F4/80–/lo MHCII+ MPs can drive T cell activation (IL-2 production) in 
vitro, although the DCs amongst these have a superior capacity [15]. The anatomical locale 
in which this occurs in vivo is unclear and is likely to be subset specific. For instance, 
although cells with the phenotypic identity of F4/80–/lo MHCII+ DC could be found in the LNs 
draining the peritoneal cavity, mature CSF1R+ F4/80–/lo MHCII+ MPs do not appear to have 
migratory capacity under steady state conditions [5], suggesting they may maintain T cells 
locally rather than participating in initial T cell priming in LNs. As stated above, another 
feature of steady state CSF1R+ F4/80–/lo MHCII+ MPs in the peritoneal and pleural cavities is 
their constitutive production of RELMa, a molecule known to have regulatory effects on T 
cells, and RALDH2 expression, from which RA could lead to imprinting of regulatory T cells. 
However, if and how RELMa and RA controls the behaviour of macrophages and/or other 
serous cavity leukocytes remains to be determined.  
 
Serous Cavity Macrophages Under Non-Homeostatic Conditions 
There are a number of pathological conditions that peritoneal macrophages have been 
implicated in, including, but not limited to, peritonitis, endometriosis, post-operative 
adhesions, pancreatitis, peritoneal cancer and acute liver injury. Thus, there is great need to 
understand the roles distinct MP subsets play when homeostasis is perturbed and the local 
factors that control their behaviour.  
 
Regulation of serous cavity macrophages during disease 
Experimental Peritonitis 
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Many studies have used sterile models of inflammation to assess macrophage population 
dynamics following perturbation of homeostasis. The commonest models include 
thioglycollate-, zymosan- and LPS-induced peritonitis. In each of these models there are 
major changes in the composition of the macrophage compartment, although the 
magnitude of these changes is highly dependent on the dose of the irritant used [12]. 
Nevertheless, a common feature of these models is the accumulation of pro-inflammatory 
F4/80–/lo MPs, which is abolished in Ccr2–/– mice, suggesting these arise from Ly6Chi classical 
monocytes [4,15,16,71-73]. F4/80–/lo monocytes/macrophages elicited by thioglycollate 
express variable levels of MHCII and have a distinct transcriptional signature from the 
CSF1R+ F4/80–/lo MHCII+ macrophages that are present under normal conditions. Notably, 
cells bearing markers or transcriptional signatures of steady state CSF1R+ F4/80–/lo MHCII+ 
macrophages appear to persist throughout peritonitis induced by thioglycollate [16], 
zymosan [15] and a cell-free bacterial supernatant [15]. Whether these cells represent the 
same F4/80lo population present prior to the onset of inflammation or newly recruited cells, 
remains unclear, although adoptive transfer experiments suggest the latter [15]. If so, there 
may be distinct fates for individual monocytes entering the inflamed cavity and it will be 
important to understand the factors controlling this process. Another common feature of 
these models is the loss of the F4/80hi macrophages in the early stages of inflammation – a 
phenomenon known as the macrophage disappearance reaction (MDR).  Again, the degree 
of loss is dependent on the dose of the irritant used to elicit inflammation [74]. The MDR has 
received much attention over the last 40 years, but whether there is unifying mechanism 
that underlies this response across models remains controversial (reviewed by [75]. 
Interestingly, in the context of liver infection, MDR by pyroptosis or necroptosis has been 
proposed to facilitate the recruitment of other immune effector cells to the site of infection 
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[76,77]. Whether this is the case in the serous cavities, especially in the context of sterile 
inflammation, remains unclear, however, the inability to undergo necroptosis appears to 
prevent the MDR in response to TLR ligation [78].    
 Further reorganisation of the macrophage compartment occurs as inflammation 
resolves. Co-incident with neutrophil clearance, the remaining F4/80hi resident macrophages 
undergo elevated proliferation via a CSF1-dependent mechanism that, in the short term, re-
establishes the bulk of the F4/80hi population [12,74]. As with the MDR, the degree of 
repopulation that occurs is dependent on the dose and type of inflammatory stimulus [12], 
but whether this relates to differences in the initial extent of MDR or the delayed resolution 
of inflammation that arises with higher inflammatory burdens is not clear. Of note, higher 
numbers of F4/80hi macrophages are found during peritoneal salmonellosis when 
inflammatory macrophage recruitment is defective [79], suggesting that the presence of 
inflammatory macrophages may, in some way, regulate F4/80hi macrophage persistence. 
Other factors may also limit the rate and degree of repopulation, for example deficiency in 
the mTORC2 complex enhances repopulation by increasing the survival and proliferation of 
resident macrophages, due in part to negative regulation of GATA6 [80]. Whether retarded 
repopulation of F4/80hi macrophages could be a contributory factor in the prolonged course 
of inflammation under certain conditions remains to be determined, but seems likely given 
the specialised role F4/80hi macrophages play in clearance of apoptotic neutrophils (see 
below). 
The fate of F4/80lo inflammatory macrophages is less clear and is complicated by 
phenotypic heterogeneity within this compartment. While a minority may migrate to the 
draining lymph nodes [81], a significant proportion appear to die by apoptosis [16]. Despite 
this, many manage to persist alongside the endogenous F4/80hi cells for at least several 
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weeks [12,16,71], and a subset defined by Ly6B expression undergo CSF1-dependent 
proliferation [74]. In the longer term (2-8wks), at least some cells recruited early during the 
inflammatory response go on to acquire a long-lived resident F4/80hi MHCIIlo phenotype 
[40,71]. As in other tissues, many un-answered questions surround the fate of recruited and 
resident macrophages, particularly regarding the identity of factors that control whether a 
cell dies or persists, and importantly, how these events are co-ordinated and contribute to 
resolution of inflammation. An as yet unexplored factor is whether the fate of a monocyte is 
restricted by the point during inflammation at which it is recruited and this requires a more 
detailed understanding of the kinetics of monocyte recruitment during inflammation. 
Notably, although the Th2 cytokine IL-4 plays a negligible role in regulation of peritoneal 
macrophages under steady state conditions [82], administration of immunocomplexes of IL-
4 and anti-IL-4, (IL-4 complex; IL-4c) can convert thioglycollated-elicited macrophages into 
F4/80hi-like macrophages [83]. Consistent with this, IL-4 can enhance GATA-6 expression in 
peritoneal macrophages in vitro [80]. However, the relative contribution of elicited F4/80lo 
macrophages to re-establishment of the F4/80hi macrophage population during resolution 
of sterile peritonitis is not clear and a role for endogenous IL-4 in this process has so far not 
been reported. 
 
Type 2 inflammation  
 Regulation of serous cavity macrophages differs dramatically under conditions of 
strong Th2-polarised inflammation, where the MDR does not appear to occur and F4/80hi 
macrophages accumulate by a process of elevated local proliferation. This first became 
apparent from studies of pleural exudate cells from mice infected with Litomosoidies 
sigmodonitis, a pleural cavity-dwelling filarial worm [84]. In this setting, proliferation is 
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largely dependent upon IL-4R signalling by macrophages [82]. Indeed, IL-4c is sufficient to 
drive proliferation and accumulation of F4/80hi cavity macrophages, as well as other tissue 
macrophages [82,84] (and SJJ unpublished observations). However, it is now clear that 
additional signals are required for macrophage proliferation in response to IL-4 that provide 
a degree of tissue-specificity. These include ligands of myosin 18A, such as SP-A in the lung 
and the complement component C1q in the peritoneal cavity and liver [85]. Notably, C1q is 
one of the most significantly up-regulated genes in peritoneal macrophages stimulated with 
IL-4 [86] and IL-4 also increases surface expression of myosin 18A by these as well as other 
tissue macrophages [85]. However, in a marked disparity with their peritoneal counterparts, 
pleural macrophages do not require C1q to proliferate in response to IL-4 [85], and so far, 
no comparable pleural cavity-specific amplifiers of proliferation have been identified. Hence, 
discrete mechanisms may control macrophage responsiveness and behaviour at these 
anatomically similar sites. Another cytokine that can stimulate proliferation of cavity 
macrophages is the pro-Th2 cytokine IL-33. While IL-33 can stimulate proliferation in the 
absence of IL-4R, unlike IL-4, it does not promote ‘alternative activation’ directly and instead 
amplifies IL-4 and IL-13 signalling to the IL-4R [87]. Notably, whether macrophage 
proliferation is fundamental to e.g. helminth expulsion remains to be determined.   
 
Function of serous cavity macrophages during disease 
Peritonitis 
The broad role of macrophages in the orchestration and resolution of the inflammatory 
events that underpin peritonitis have been studied extensively. However, comparably few 
studies have attempted to define the individual roles played by discrete mononuclear 
phagocyte subsets. For instance, although clodronate-depletion studies have been used to 
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show that peritoneal macrophages play a role in the increased vascular permeability seen in 
the very first phase of zymosan-induced peritonitis [88], whether this is a role of F4/80hi or 
F4/80lo macrophages remains unclear. Peritoneal macrophages are also implicated in the 
recruitment of neutrophils during initiation of acute peritonitis [89] and this is likely to 
involve the F4/80hi population because neutrophil accumulation during thioglycollate- 
[72,73], zymosan- [71] and salmonella-induced peritonitis [79] is unaffected in Ccr2–/– mice, 
in whom the F4/80–/lo MHCII+ peritoneal macrophage population is essentially absent 
[5,14,15,26]. Notably, neutrophils can enter the cavity via high endothelial venules (HEV) in 
the omentum [90] and thus regulation of neutrophil recruitment could be a role for 
omentum-dwelling macrophages. However, this may by model-dependent, since neutrophil 
recruitment is normal during zymosan-induced peritonitis in mice with depleted 
macrophage compartments [11,91]. F4/80hi macrophages that persist during peritonitis may 
also maintain a regulatory role by, for example, increased production of IL-10 [15]. Indeed, 
F4/80hi macrophages appear to be the predominant myeloid source of IL-10 during 
peritonitis and enhanced neutrophil and inflammatory F4/80lo macrophage accumulation is 
seen in global Il10–/– mice [15].  
 The function of inflammatory F4/80lo macrophages during peritonitis remains 
relatively poorly understood, although it is clear that they produce high levels of pro-
inflammatory cytokines, such as TNFa, IL-1b and IFNg [79]. Combined with their superior 
ability to engulf microbial particles [92], inflammatory F4/80lo macrophages appear to be the 
predominant iNOS expressing cell during peritoneal salmonellosis, suggesting they also 
play crucial role in bacterial elimination [79]. Notably, although many inflammatory F4/80lo 
macrophages express MHCII, they are less able to present antigen to and cause activation 
of T cells [15], and fail to upregulate many of the signature genes of their homeostatic 
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F4/80lo MHCII+ counterparts, including Cd226, Fcrls and Aldh1a2 [15,16]. This may reflect 
the failure of inflammatory F4/80lo macrophages to upregulate the transcription factor IRF4 
[16], which is required for homeostatic differentiation of F4/80lo MHCII+ macrophages [14]. 
Thus, differentiation of classical Ly6Chi monocytes in the inflamed cavity appears to follow a 
distinct pathway. Interestingly, inflammatory F4/80lo macrophages express high levels of the 
CSF2R [16], which could implicate CSF2 (GM-CSF) in their differentiation, although this 
remains to be determined experimentally. 
Macrophages are also central players in the resolution of peritoneal inflammation. In 
particular, they are considered the main scavengers of dying cells during and following an 
inflammatory insult. In this way, clearance of the large number of neutrophils recruited at the 
onset of inflammation is considered an essential step in the promotion of the resolution of 
inflammation, and this is thought to induce an anti-inflammatory programme in 
inflammatory macrophages, including enhanced production of immunoregulatory cytokines, 
such as IL-10, TGFb and RELMa [71,93]. This may support the expansion of regulatory T 
cells that is reported to occur during peritonitis resolution [71]. Uptake of apoptotic cells 
(efferocytosis) also blunts production of pro-inflammatory cytokines, and at least in the case 
of TNFa, is dependent on CD73, the enzyme that catalyses conversion of AMP to adenosine 
and is a signature marker of F4/80hi macrophages [94]. Efferocytosis can occur via a variety 
of receptors but most of these require specific ligands on the surface of target cells, such as 
phosphatidyl-serine, to be bound by secreted ‘opsonins’, such as milk fat globule-EGF 
factor 8 (Mfge8) protein [95]. However, in the peritoneal cavity, F4/80hi resident 
macrophages express exceptionally high levels of Tim4 , a receptor that directly recognises 
phosphatidyl-serine on the surface of apoptotic cells [96,97]. Notably, although depleted in 
terms of cell number, F4/80hi macrophages appear to be the most efficient at uptake of 
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apoptotic cells [16]. Moreover, their capacity to sequester free Mfge8 by expressing 
modified lipids on their cell surface, limits efferocytosis by Tim4–/lo inflammatory 
macrophages [98], which express high levels of Mfge8 [16]. Hence, it seems a strategy has 
evolved that allows efficient and preferential apoptotic cell removal by resident F4/80hi 
macrophages. While the purpose of this mechanism is unclear, deficiency in the enzyme 
12/15-lipoxygenase (encoded by Alox15), which is required by F4/80hi to modify lipids, 
results in the development of lupus-like disease, and this has been attributed to uptake of 
apoptotic cells by recruited monocyte-derived ‘inflammatory’ macrophages [98]. That Tim4 
deficient mice develop antibodies to dsDNA following immunisation, would seemingly 
support this hypothesis [97]. Indeed, induction of Tim4 expression by peritoneal F4/80hi 
seems to accompany increased expression of negative regulators of TLR signalling, and loss 
of expression of TLR9, the cytosolic TLR that recognises DNA [47]. Thus, mechanisms exist 
to allow safe removal of apoptotic cells in the peritoneal cavity. 
Other mechanisms to ensure successful removal of apoptotic/necrotic cells from the 
peritoneum have been uncovered recently. For instance, production of CD5L (also known as 
apoptosis inhibitor of macrophage; AIM) by macrophages may also facilitate removal of 
necrotic cell material, as the resolution of zymosan-induced peritonitis is delayed in CD5L 
deficient mice [99]. However, the source of CD5L is unclear because both homeostatic 
F4/80hi macrophages and inflammatory F4/80lo cells express high levels of Cd5l [9,16]. 
Furthermore, macrophages present during the resolution phase of zymosan-induced 
peritonitis produce high levels of CCL5 [71] which may act to recruit other pro-restorative 
leukocytes, but also enhance efferocytosis by binding to the atypical chemokine receptor 
ACKR2 (also known as D6) on neutrophils [100].  
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Type 2 Inflammation 
Th2-dominated inflammation, such as that associated with helminth infection, is 
characterised by high levels of IL-5, IL-10, IL-13, and in particular IL-4. In addition to 
inducing in situ proliferation of macrophages, IL-4R signalling is known to cause ‘alternative 
activation’ of macrophages, which is characterised by production of arginase, RELMa, Ym-1 
and TGFb [101]. Alternatively activated macrophages are important for the wound healing 
following helminth invasion, which may involve promoting eosinophil recruitment [102]. 
Moreover, alternatively activated macrophages produce growth factors such as insulin-like 
growth factor (IGF)-1 and platelet-derived growth factor (PDGF), which promote collagen 
deposition, fibroblast proliferation and myofibroblast differentiation to facilitate effective 
tissue repair following injury/insult [103]. However, while eosinophils have a well-defined roll 
in helminth expulsion in the serous cavities [104], the relative roles for these macrophage-
derived products in this process remains to be determined with certainty. Importantly, it has 
recently been shown in vivo that helminth-expanded F4/80hi macrophages can switch to 
bactericidal, iNOS-expressing macrophages during a subsequent salmonella challenge [79], 
demonstrating that functional plasticity exists in resident serous cavity macrophages in an 
infectious setting. 
 
Role of serous cavity macrophages in non-cavity conditions  
While much of the work examining the properties of peritoneal mononuclear phagocytes 
during disease has utilised models of sterile inflammation of the cavity directly, recent data 
suggest that these cells could have wider roles in regulating inflammation in neighbouring 
tissues. For instance, infection with the intestinal parasite Heligmosomoides polygyrus leads 
to elevated proliferation and alternative activation of peritoneal F4/80hi macrophages 
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[79,82], while Alternaria alternata-induced airway inflammation generates the same response 
by resident F4/80hi pleural macrophages [87]. The significance of bolstering the macrophage 
compartment of the serous cavity in response to inflammation in neighbouring tissues 
remains unclear, although this may rely on IL-33 to promote tissue repair functions by these 
cells. Indeed, as discussed above, IL-33 can induce proliferation and alternative activation of 
cavity macrophages [87], and adoptive transfer of IL-33-treated peritoneal macrophages 
appears to protect mice from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis 
[105] and promote expulsion of the intestinal parasite Heligmosomoides bakeri [106]. 
Whether serous cavity macrophages enter these neighbouring tissues to promote repair 
remains unclear, although they have been shown to migrate to the liver in a CD44-
dependent manner following thermal injury of the liver capsule [107].  Here they undergo 
alternative activation, characterised by high levels of arginase and CD206 expression, to 
promote tissue repair [107]. While this represents a novel reparative function of these cells, 
it will be important to determine if peritoneal F4/80hi macrophages play a similar role in e.g. 
acetaminophen-induced liver injury, which represents a more clinically relevant model of 
liver injury.  
While macrophages can perform beneficial, pro-restorative roles, they are also 
implicated in many chronic inflammatory pathologies and cancer. One such pathology of 
the peritoneal cavity is endometriosis, a condition characterised by ectopic endometrial 
tissue on the peritoneum that affects 10% of women of reproductive age [108]. In addition 
to increases in their numbers, peritoneal macrophages obtained from women with 
endometriosis have heightened basal production of pro-inflammatory cytokines, including 
TNFa, IL-1b and IL-8, and exaggerated responses to stimulation with TLR ligands, such as 
LPS [109,110]. Endometrial lesions are rich in immune cells and, in particular, macrophages. 
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High levels of monocyte/macrophage chemoattractants CCL2, CCL3 and CCL5 present in 
lesions attracts macrophages [111,112], although it remains to be shown definitively that 
mature peritoneal macrophages, or particular subsets, enter endometrial lesions. Similarly, 
peritoneal macrophage function is altered in acute pancreatitis [113], where they show 
enhanced levels of pro-inflammatory cytokine production, but the subset responsible for this 
and if these migrate to the pancreas remains unclear. 
 Macrophages are also implicated in the formation of peritoneal adhesions, a 
common issue following abdominal surgery. However, their exact role remains unclear 
because although depletion of macrophages using the Macrophage Fas-Induced Apoptosis 
(MAFIA)-mouse [114] was shown to elicit peritoneal adhesions [115], depletion with 
clodronate liposomes led to reduced adhesion formation in post-operative adhesion model, 
which was attributed to a reduction in macrophage-derived epidermal growth factor (EGF) 
[116]. Thus, more work is needed to elucidate the role of peritoneal macrophages, and their 
subsets, in this condition.  
The peritoneum is also a common site for metastases of epithelial cancers, such as 
ovarian, colon and gastric carcinomas [1]. Moreover, malignant mesothelioma is a highly 
aggressive cancer resulting from neoplastic transformation of mesothelial cells in the body 
cavities, although around 95% of cases affect the pleurae. That clodronate-mediated 
depletion of macrophages reduced tumour burden and metastasis in a model of peritoneal 
mesothelioma [117] and ovarian cancer [118], suggests serous cavity macrophages promote 
tumorigenesis. Notably, phenotypic and functional alterations have been reported in 
mononuclear phagocytes from patients with ovarian carcinoma [119], and pleural effusion 
from malignant mesothelioma patients induces differentiation of macrophages with 
enhanced suppressive capacity in vitro [120]. However, again, how cavity macrophages 
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contribute to tumour establishment and growth requires further study and like in different 
cancers, cavity macrophages are likely to play dichotomous roles depending on the stage of 
the disease [121].  
  
Conclusions and future perspectives 
The last decade has seen unprecedented advances in our understanding of mononuclear 
phagocyte heterogeneity, origin and function. Thus, while once simply considered a 
convenient source of macrophages, the serous cavities are now considered to have a highly 
diverse mononuclear phagocyte system. Nevertheless, how distinct populations of 
macrophages contribute to disease pathogenesis and/or tissue repair, and the factors that 
control their function in different contexts remain poorly characterised. Therefore, the focus 
now must be to understand these processes in clinically-relevant models of disease affecting 
the serous cavities and the organs they cover. 
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Figure Legends 
Figure 1: Heterogeneity, ontogeny and growth factor dependence of peritoneal 
mononuclear phagocytes. Resident macrophages in the healthy serous cavities are 
characterised by their high expression of F4/80, CD11b and CD102, as well as low levels of 
MHCII. They also express high levels of CD93, CD73, CD49F and many express the 
phagocytic receptor Tim4. These F4/80hi macrophages dominate the cavity under normal 
physiological conditions and rely on number of transcription factors for their full 
differentiation, including GATA6, C/EBPb, KLF2 and KLF4 [11,13,17,26,47]. Although 
F4/80hi macrophages initially arise from embryo-derived precursors, these are progressively 
displaced by bone marrow-derived macrophages in a process that is highly influenced by 
age, and in the peritoneal cavity, the sex of the animal [5]. F4/80hi macrophages exist 
alongside a much smaller population of ‘F4/80lo’ macrophages that express high levels of 
CSF1R, MHCII, CD226 and the immunoregulatory cytokine RELMa. F4/80loMHCII+ 
macrophages are short-lived and are continually replaced by Ly6Chi classical monocytes, 
which enter the cavity in a CCR2-dependent manner and mature locally under the control of 
CSF1. The microbiota or its derivatives may also influence this differentiation process, along 
with other, as yet unidentified, environmental factors. These are distinct from conventional 
dendritic cells that are replenished by CCR2-independent precursors, rely on Flt3L for their 
development and can be divided into cDC1 and cDC2 subsets on the basis of CD103/XCR1 
and CD11b expression, respectively [5,6,15]. F4/80loMHCII+ macrophages may also act, in 
part, as precursors of F4/80hi macrophages [5]. Peritoneal macrophages are known to be 
able to migrate to the omentum and the differentiation of F4/80hi macrophages relies on the 
vitamin A metabolite, retinoic acid, which is thought to be provided by cells in the omentum 
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[26]. However, whether differentiation of F4/80hi macrophages occurs locally in the 
peritoneal cavity or if cells are ‘educated’ in the omentum remains unclear. 
 
 
Figure 2: Homeostatic functions of peritoneal macrophage subsets. Resident F4/80hi 
macrophages express an array of phagocytic receptors, such as Tim4, MerTK and CD36 that 
allows them to take up and eliminate apoptotic cells. Notably, apoptotic cells accumulate 
when this process is defective [97]. They may also control the composition of the serous 
cavity fluid by regulating the levels of surfactant in serous cavity fluid. F4/80hi also play a 
crucial role in immune surveillance and their high phagocytic activity means that they can 
capture and destroy any pathogenic intruders. Through their production of the chemokine 
CXCL13, they also regulate the recruitment and maintenance of B1 B cells, which are key 
producers of natural IgM [122]. The functions of F4/80lo MHCII+ macrophages are less well 
understood, although their high levels of MHCII and costimulatory molecules indicates a 
role in antigen presentation. These cells do not actively migrate to lymph nodes during 
homeostatic conditions, suggesting that they may be involved in local antigen presentation 
and maintenance of the serous cavity T cell pool. A defining feature of F4/80lo MHCII+ 
macrophages under homeostatic conditions is the constitutive production of RELMa. 
Furthermore, they also express high levels of RALDH2, suggesting they may be a rich source 
of retinoic acid. The role of macrophage-derived RELMa and RA in serous cavity 
homeostasis remain unclear. 
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